MimiVax, Inc., a leader in clinical-stage pharmaceutical research, today announced that its now fully enrolled Phase 2b clinical trial of SurVaxM in glioblastoma

TC BioPharm PLC a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications

OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation

Actinogen Limited announces that the publication of its most recent peer-reviewed article entitled Clinical Pharmacology and Approach to Dose Selection

Kexing Biopharm Co., Ltd. recently announced that the Investigational New Drug Application

Today, the U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control

Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides in penetrating the Canadian and US markets

Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation associated with osteoarthritis

BioRay Pharmaceutical Co., Ltd. announced that the National Medical Products Administration (NMPA) has accepted the clinical trial

PharmaTher Holdings Ltd. a specialty pharmaceutical company seeking FDA approval for ketamine, today announced that the Company